The CDC has updated its 2024 U.S. Selected Practice Recommendations for Contraceptive Use, recommending lidocaine for pain management during IUD placement and advising against routine use of misoprostol. In a recent Q&A, experts discussed the importance of counseling patients about potential pain during IUD placement and the risks and benefits of pain management options. Other top stories in women’s health include findings that induction at 37 weeks’ gestation did not reduce maternal outcomes in women with mild chronic hypertension, domestic violence is linked to chronic pain development, severe menopause symptoms are associated with cognitive impairment, and uterus transplant is feasible with a high live birth rate.
Source link
IUD placement guidance; early delivery on maternal outcomes
